Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
June 10, 2026
Ethyreal Bio Launches With $101 Million to Advance Potential Disease-Modifying Therapy for TED
AAO Partners with OpenEvidence to Bring Specialty Guidelines Directly Into AI Clinical Workflow
June 9, 2026
Optos Appoints Alexandre Montague as Chief Executive Officer
Heidelberg Engineering Receives FDA Clearance for Enhanced Imaging Software on Spectralis
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
